Brief: Ifresh Agreea To Acquire 70% Equity Interests In Xiamen Dl Medical Technology
March 17 (Reuters) - iFresh Inc IFMK.O :
* IFRESH SIGNS PURCHASE AGREEMENT TO ACQUIRE 70% EQUITY
INTERESTS
IN XIAMEN DL MEDICAL TECHNOLOGY
Source text for Eikon: ID:nGNX4YN4fK
Further company coverage: IFMK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on iFresh
See all newsBrief: Ifresh Through An Attorney, Responds To SEC Allegations
Brief: iFresh Announces Nasdaq Delisting
U.S. STOCKS ON THE MOVE-PubMatic, Unity Biotech, Seres Therapeutics
IFresh sees best day in 9 months on partnership with Alibaba's Tmall
Brief: iFresh Partners With Tmall Global To Enter Cross-Border Trade E-Commerce Market In China